Syntec Optics Holdings, Inc. (OPTX) Earnings Call Transcript
November 17, 2026
Earnings Call Speaker Segments
Hello, and welcome to the Syntec Optics Holdings, Inc. Third Quarter 2026 Earnings Conference Call. <<operator_script>> I'd like to point out that this call is being recorded today and a replay will be made available on the company's website. Before we get started, I want to remind everyone that our discussion today contains forward-looking statements as defined under the federal securities laws. Among the things these statements cover are expectations about customer programs, future revenue growth, profitability, production ramps, capital investments and strategic opportunities. Such statements rest on current expectations and carry risks and uncertainties that could cause actual results to differ materially. For a fuller discussion of these risks, please see the company's filings with the Securities and Exchange Commission, including its Form 10-K and Form 10-Q filings. Except as required by law, Syntec Optics assumes no obligation to update any forward-looking statements. Adjusted EBITDA, which is a non-GAAP financial measure, will also be discussed today. This measure is a supplement to, and should not be viewed as a replacement for, results prepared in accordance with GAAP. The definition of adjusted EBITDA, along with its reconciliation to GAAP net income or loss, can be found in the company's third quarter Form 10-Q. With us today are Dean Rudy, Chief Financial Officer, and myself, Paul Opela, Controller at Syntec Optics. I'll now hand the call over to Dean Rudy.
Thanks, Paul, and good afternoon to all of you; we're grateful you could join us today for a discussion of Syntec Optics' results for the third quarter of 2026. During our previous call, we went over 4 developments that are shaping Syntec: better operating performance, several engines of growth, a stronger balance sheet and a growing set of opportunities. The results we posted for the third quarter demonstrate ongoing progress on each of those fronts. To begin, revenue hit yet another all-time quarterly record of roughly $8.5 million, which is a 23% rise compared with the same period a year earlier. Gross profit grew by more than twofold, and we delivered positive operating income as well as net income. Adjusted EBITDA came in at about $0.9 million, equal to 10% of revenue. Next, we are broadening our involvement in customer programs spanning defense, space, life sciences and AI infrastructure. Defense Tech and Space Tech combined accounted for roughly 64% of revenue in the quarter, and Life Sciences keeps supplying a substantial and well-diversified base of revenue. Third, our financial position is still solid. We finished September with about $14.4 million of cash, higher than the roughly $14 million we held at the close of June, and we produced approximately $1.3 million in operating cash flow across the first 9 months of the year; and fourth, we keep finding ways to leverage our available capacity, bring on additional manufacturing capabilities and back our customers as development programs advance toward recurring production. A good number of these programs carry product life cycles spanning 7 to 10 years and call for replacement products as time goes on. What we are focused on is securing a bigger role within those customer platforms. All told, we believe these developments reinforce the groundwork for lasting revenue growth and better profitability. With that summary complete, I'll hand the call to Paul so he can walk through the financial results in greater detail.
Thanks, Dean. As Dean noted, third-quarter 2026 revenue was about $8.5 million, up 23% from the roughly $7 million recorded in Q3 2025. Beginning with this quarter, we are reporting revenue split across five end markets: Space Tech, Defense Tech, Life Sciences, AI, data center and power, and others, including scientific instruments. This illustrates which applications our products support and what demand drivers are shaping the business. Prior-year figures have been reclassified to keep comparisons consistent, with no impact on total revenue or on the timing of revenue recognition. Since these are end market categories, the company continues to have a single reportable segment for GAAP purposes. Defense Tech led as our largest end market, generating roughly $4.2 million in revenue—a 31% year-over-year increase—and representing 49% of quarterly revenue. Revenue from Space Tech climbed 117% to about $1.3 million, equal to 15% of quarterly revenue, making it the fastest-growing end market this quarter. Life Sciences revenue increased 12% to approximately $2.7 million, which comes to 31% of our quarterly revenue. AI, data center and power brought in about $200,000, or 2%, including scientific instruments. Gross profit jumped 127% to roughly $1.9 million, compared with approximately $0.9 million in the prior year quarter. Gross margin came in at roughly 23%, versus about 12% in the same period last year; our goal remains an additional 10% improvement in gross margin, which would bring adjusted EBITDA to 20%. This year-over-year gain resulted from increased revenue combined with a relatively small increase in cost of goods sold. SG&A expenses totaled about $1.7 million, a decrease of roughly $0.3 million from the prior-year quarter. Operating income stood at approximately $0.2 million, compared with an operating loss of about $1.2 million in the year-earlier period. Net income was about $0.2 million, equal to $0.01 per basic share and diluted share, versus a net loss of $1.4 million, or $0.04 per share, in the third quarter of 2025. On a year-over-year basis, that's an improvement of roughly $1.6 million. Adjusted EBITDA came in at about $800,000, which works out to 10% of revenue; in the prior year quarter it was approximately negative $16,000 — basically breakeven — so this is a very large improvement. As we mentioned earlier, adjusted EBITDA is a non-GAAP measure, and you can find both its definition and the reconciliation in our Form 10-Q. Turning now to liquidity: cash was approximately $14.4 million as of September 30, versus $14 million on June 30. During the first 9 months of 2026, operating activities produced roughly $1.3 million in cash, compared with $0.7 million during the same period a year ago. Our financial position was substantially strengthened by the equity financing we completed earlier this year along with the repayment of our revolving line of credit. In our view, having that cash on hand lets us stay flexible—meeting what customers need, making targeted investments in manufacturing capacity, and assessing growth opportunities that fit alongside our business. Dean, over to you for the operational and strategic update.
Thanks, Paul. I want to go back to the 4 themes we talked about on our previous call and look at how each one is progressing. First, better operating performance. Our record revenue for the third quarter and our return to profitability versus the same quarter a year earlier demonstrate the headway we're making. Gross profit rose substantially, and selling, general and administrative expenses came down. Almost 12 months after we first discussed these ideas, we're now putting them into practice. We're simplifying the way information travels across the manufacturing floor so that it aligns with our material flow, delivering the right details to the right location at the right moment. That means fewer instances of miscommunication and misaligned efforts, which helps us launch more quickly and steer clear of expensive mistakes. Second, multiple engines of growth. The breadth of our customer programs is the second theme. Our refreshed end market presentation makes that breadth simpler to grasp. In Space Tech, our products back low earth orbit satellites, debris detection and collision avoidance, reconnaissance and lunar mission hardware. In the third quarter, we announced orders that widen our involvement in orbital safety and government satellite reconnaissance. Those product lines extend our space business across numerous programs and mission requirements. After the quarter closed, we announced production orders for actuator products that support NASA's Artemis III rockets. As we reported in our October announcement, that order lifted Space Tech backlog by 10%. It also stretches our space portfolio beyond satellites into hardware that supports lunar missions. In Defense Tech, our products back AI-enabled augmented and virtual reality soldier systems, night vision, missile guidance and laser targeting. These are mission-critical applications inside established defense priorities that carry across administrations. Announcements this year included camera and display window products for military wearable systems, widening our involvement within customer platforms. The opportunity isn't confined to winning current product; as customers succeed with their systems and with us as a mission-critical product provider, we aim to add products and capabilities within the same or other platforms and to support them throughout their program life cycles. Life Sciences stays an important piece of that diversified base. Our products serve blood diagnostics for early disease detection, biomedical illumination and visualization, surgical robotics and DNA sequencing. Earlier in the year, we announced a $4.6 million follow-on order for blood test cartridges and optical reader subsystems, plus roughly $4.0 million of additional recurring Life Sciences orders spanning surgical robots, DNA sequencing ophthalmology and veterinary care. These programs complement our expanding Defense and Space businesses. Theme number three, a stronger financial platform. What our cash position lets us do is the third theme. Customers developing next-generation technologies need suppliers able to support their transition into recurring high-volume production. Our financial position gives us the flexibility to invest alongside those customers. That covers adding selected manufacturing capabilities, improving automation and metrology and using the open capacity already available within our facility; we will keep evaluating investments based on customer requirements, execution needs and expected returns. What we're aiming for is turning that stronger financial platform into ongoing expansion and better profitability. Item number 4: a growing set of opportunities. Theme four concerns the chance to widen the part Syntec plays in the technologies that link and safeguard the globe. Across AI infrastructure, space systems, defense platforms and life sciences, we perceive one shared requirement for vision optics. Because of what we can do in optical manufacturing, coating, assembly and metrology, we're able to handle a range of applications as our customers' technologies develop. In AI infrastructure, our work covers precision micro connectors for transceivers and photonic integrated circuits, plus optics that support emerging space-based solar and earth-based fusion energy uses; these opportunities take in both moving data and backing the power infrastructure that future computing demand will require. Back in August, we disclosed roughly $4.0 million of cumulative orders spanning the wider AI infrastructure opportunity since we came into that market about 2 years ago. Right now, AI Data Center and Power revenue is still modest and has felt the impact of product transition timing at a major customer. As we noted in our Form 10-Q, we anticipate new product launches in early 2027 will help this category rebound. Additional scientific instrument applications, among them certain quantum computing activity, widen the range of markets our capacities are able to serve; we likewise keep assessing complementary strategic opportunities capable of broadening our technology portfolio, customer relationships or manufacturing capabilities. Our stance stays disciplined, centered on opportunities that can be integrated well and generate long-term shareholder value. As we look toward the fourth quarter and past it, we're concentrating on bringing in customer programs able to use the capacity we have available and sustain long product life cycles; Defense and Space, we believe, present meaningful growth opportunities, backed by our growing participation in connected battlefield technologies, orbital safety, reconnaissance and lunar mission hardware. Life Sciences keeps supplying a substantial revenue base, while AI infrastructure holds out further opportunities as customer product transitions move forward. Syntec has announced several key program wins of late. Next, our new business teams are aiming at the future of the connected battlefield with next-generation camera technologies. Through advanced microstructures and metalenses, our systems will peer deeper into the infrared spectrum to counter enemy concealment, pick up weaker signals and lower overall weight and power demands. We're also working toward adding programs that will let us deliver not just precision engineered products but tools that build in ultraprecision. In years past, we talked about the future. Those programs now exist. Now we fix our sights on the next frontier. We can get there sooner if we think hard. Our fresh long-term priorities stay simple: execute customer programs, use available capacity effectively, improve manufacturing economics and invest selectively behind customer demand. Production ramp timing, customer orders and tooling milestones will keep shaping quarterly results. Our focus stays on turning the opportunities in front of us into durable revenue growth and better profitability; we closed the third quarter with record revenue, profitability that improved versus a year ago, a diversified set of customer programs, and a solid cash position. We think Syntec is positioned well to extend its momentum in defense and space while still supporting key Life Sciences and Emerging AI picks and shovels type applications. What we aim for is a bigger, more profitable technology company, achieved through disciplined execution and capital allocation. Thanks go to our employees for their hard work, to our customers for their trust, and to our shareholders for their continued support. With that, I will hand the call back over to Paul.
Appreciate that, Dean, for sharing your thoughts with us today. If anything comes up about Syntec Optics’ earnings results or our strategic initiatives, you can reach Investor Relations by e-mail at investorrelations@syntecoptics.com. To be clear, that is Investorrelations as one word, @syntecoptics.com. A replay of today’s call is going to be posted in the Investor Relations section of the company’s website at www.syntecoptics.com. Thanks for being with us today, and have a great evening.
For developers and AI pipelines
Programmatic access to Syntec Optics Holdings, Inc. earnings transcripts and 131,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.